Laboratorios Farmaceúticos Rovi SA (LABFF)
65.86
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Laboratorios Farmaceúticos Rovi Total Liabilities (Quarterly) : 276.05M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 276.05M |
| December 31, 2025 | 325.08M |
| September 30, 2025 | 339.89M |
| June 30, 2025 | 341.71M |
| March 31, 2025 | 231.70M |
| December 31, 2024 | 258.41M |
| September 30, 2024 | 356.76M |
| June 30, 2024 | 400.22M |
| March 31, 2024 | 275.28M |
| December 31, 2023 | 281.72M |
| September 30, 2023 | 292.31M |
| June 30, 2023 | 412.93M |
| March 31, 2023 | 343.75M |
| December 31, 2022 | 379.46M |
| September 30, 2022 | 322.48M |
| June 30, 2022 | 407.00M |
| March 31, 2022 | 355.11M |
| December 31, 2021 | 294.95M |
| September 30, 2021 | 268.92M |
| June 30, 2021 | 282.13M |
| March 31, 2021 | 228.05M |
| December 31, 2020 | 242.30M |
| September 30, 2020 | 225.45M |
| June 30, 2020 | 211.86M |
| March 31, 2020 | 208.86M |
| Date | Value |
|---|---|
| December 31, 2019 | 208.43M |
| September 30, 2019 | 150.85M |
| June 30, 2019 | 170.61M |
| March 31, 2019 | 149.58M |
| December 31, 2018 | 127.58M |
| September 30, 2018 | 133.64M |
| June 30, 2018 | 134.53M |
| March 31, 2018 | 133.68M |
| December 31, 2017 | 123.11M |
| September 30, 2017 | 116.08M |
| June 30, 2017 | 128.75M |
| March 31, 2017 | 119.71M |
| December 31, 2016 | 105.27M |
| September 30, 2016 | 103.74M |
| June 30, 2016 | 114.53M |
| March 31, 2016 | 104.18M |
| December 31, 2015 | 89.24M |
| September 30, 2015 | 111.47M |
| June 30, 2015 | 117.35M |
| March 31, 2015 | 103.90M |
| December 31, 2014 | 101.27M |
| September 30, 2014 | 114.75M |
| June 30, 2014 | 132.10M |
| March 31, 2014 | 119.39M |
| December 31, 2013 | 85.95M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Almirall SA | 947.80M |
| AstraZeneca PLC | 66.63B |
| ANI Pharmaceuticals, Inc. | 859.67M |
| Corcept Therapeutics, Inc. | 176.89M |
| Assertio Holdings, Inc. | 135.67M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.067B |
| Shareholders Equity (Quarterly) | 776.47M |
| Debt to Equity Ratio | 0.1698 |
| Current Ratio | 3.655 |
| Net Debt Paydown Yield | -0.08% |